{'text': 'Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign', 'publisher': {'href': 'https://www.businesswire.com', 'title': 'Business Wire'}, 'created_at': 'Thu, 04 Jun 2015 07:00:00 GMT', 'description': 'Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign  Business Wire', 'url': 'https://news.google.com/rss/articles/CBMi5wFBVV95cUxNVmg5VWVZM1FtNlZLTHhoMXVlUHVMb0NMVGZpN01GUzNERXJNNkczQXFkNTN6aThXVmktLURsTjZSdGxELTlVdjB0LTRiYWtEczZDWEJzQVVBV2N6b2hqSDJiV0I2cnZaVjhRb3FCWWpBOHdXZzBkdXVjMDMzT0tsb3lpRGlhdXJIZDdycnBtWjMySUNWV3QzNEphNFVzMlQ2YTdJUmFVWjVnZnpYZThfelZ0ZGpobkJhSzdsTEZHcFpKdnBEM1dIVUM2RzJtX082alV1a2YzTV95MDFoWXdxSmpJTE1qWG8?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Pink pill: First female libido drug awaits U.S. OK as safety, merits face scrutiny', 'publisher': {'href': 'https://www.japantimes.co.jp', 'title': 'The Japan Times'}, 'created_at': 'Wed, 03 Jun 2015 07:00:00 GMT', 'description': 'Pink pill: First female libido drug awaits U.S. OK as safety, merits face scrutiny  The Japan Times', 'url': 'https://news.google.com/rss/articles/CBMi4wFBVV95cUxOeDRTbUg3UFdCeUN2czc4WWRfXzFMaDF0cGQ4TTQwYVlTWmxPcWNEdDd2VHkxVGJuVjVUSkVSZ01UU1JXU2EyRkxLeUM2QVV4NkptQ28xVjMwcmFZbkEzbW5PbWVhNVJhLUxSYUNsQjA2bjNoT19udldzeVBocVZxTFhFQml6UUR5WmpRWHdxalV2NFVNTjJZOWNPTWl3MkRPMlI3SExDcUw0bHdpSjhpVE0xZkdnM0ZscTlFc1hubWxiYVlsWkV4dEZvb3ZwQy1MZDcyVmZpT2o1YmZBQ1JOYXN3aw?oc=5&hl=en-US&gl=US&ceid=US:en'}
